Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inflammatory Response Research

Inflammatory Response Research
2011 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$980K LATEST DEAL AMOUNT
Description

Provider of drug development services intended to develop drugs for inflammatory disorders. The company'sdrug development service focuses on pharmaceutical products for the treatment of inflammatory disorders and conditions. the company's products are oral combination of levocetirizine and montelukast for the treatment of influenza, enabling patients to recover inflammatory disorders.

Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 515 East Micheltorena
  • Suite G
  • Santa Barbara, CA 93103
  • United States

+1 (805) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inflammatory Response Research’s full profile, request a free trial.

Inflammatory Response Research Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 20-Nov-2017 $980K 00.000 Completed Startup
2. Angel (individual) 04-Oct-2016 0000 00000 Completed Startup
1. Angel (individual) 02-Dec-2014 $860K $860K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Inflammatory Response Research Executive Team (2)

Name Title Board
Seat
Contact
Info
Chandler May MD Co-Founder, Vice President, Board Member, President & Chief Executive Officer
Loriel May Co-Founder, Board Member & Chief Financial Officer